IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q2 2024 Holdings

Filed 2024-08-13 | 3 holdings | $6.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tscan Therapeutics Inc(TCRX)COM89854M101$3.7M630,00061.2%
Werewolf Therapeutics Inc(HOWL)COM95075A107$1.4M589,10223.9%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$899.1K642,20414.9%